SVB Wealth LLC Makes New Investment in Agilent Technologies, Inc. (NYSE:A)

SVB Wealth LLC purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 55,886 shares of the medical research company’s stock, valued at approximately $7,508,000.

Other institutional investors also recently added to or reduced their stakes in the company. Van ECK Associates Corp increased its holdings in shares of Agilent Technologies by 6.6% in the third quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock valued at $442,011,000 after purchasing an additional 183,716 shares during the period. Vestal Point Capital LP acquired a new position in shares of Agilent Technologies in the third quarter valued at approximately $14,848,000. Empowered Funds LLC increased its holdings in shares of Agilent Technologies by 29.8% in the third quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company’s stock valued at $4,592,000 after purchasing an additional 7,111 shares during the period. S.E.E.D. Planning Group LLC increased its holdings in shares of Agilent Technologies by 12.7% in the fourth quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock valued at $5,721,000 after purchasing an additional 4,805 shares during the period. Finally, National Pension Service increased its holdings in shares of Agilent Technologies by 10.8% in the third quarter. National Pension Service now owns 702,631 shares of the medical research company’s stock valued at $104,327,000 after purchasing an additional 68,670 shares during the period.

Analyst Ratings Changes

A has been the topic of a number of analyst reports. JPMorgan Chase & Co. decreased their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. Bank of America decreased their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research note on Friday, December 13th. Wells Fargo & Company decreased their price target on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. Citigroup lifted their price target on Agilent Technologies to $165.00 and gave the company a “buy” rating in a research note on Thursday, December 19th. Finally, Sanford C. Bernstein decreased their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $146.15.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Agilent Technologies Stock Up 0.6 %

Shares of NYSE:A opened at $127.83 on Friday. The company has a quick ratio of 1.58, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35. The stock’s fifty day simple moving average is $140.64 and its 200-day simple moving average is $139.14. The company has a market capitalization of $36.47 billion, a P/E ratio of 29.39, a P/E/G ratio of 3.44 and a beta of 1.07.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.78%. Agilent Technologies’s payout ratio is currently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.